| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Lindstrom Richard L Md serves as a Director at LNSR and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 4 buys and 6 sells. Those positions are worth an estimated $329K at current prices.
Historically, Lindstrom Richard L Md's trades have earned a middling insider score of 65/100 across 7 rated trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +19.0%.
The biggest single holding is HROW (~$329K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 26,100 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | OCUL Ocular Therapeutix, Inc. | Director | Buy | 60,229 | $7.66 | $461,354.14 | +32.3% | +5.7% | - | |
| May 8, 2025 | OCUL Ocular Therapeutix, Inc | Director | Buy | 10,000 | $6.96 | $69,600.00 | +6.1% | +67.8% | - | |
| Sep 30, 2022 | HROW Harrow, Inc. | Director | Sell | 40,000 | $12.62 | $504,800.00 | -60.5% | +22.5% | +19.1% | |
| Sep 24, 2021 | HROW Harrow, Inc. | Director | Sell | 3,900 | $10.04 | $39,156.00 | -5.6% | -3.1% | -15.8% | |
| Sep 16, 2021 | HROW Harrow, Inc. | Director | Sell | 20,000 | $9.07 | $181,391.20 | -22.2% | -6.9% | -2.2% | |
| May 20, 2021 | OCUL Ocular Therapeutix, Inc | Director | Sell | 10,000 | $14.30 | $143,000.00 | -10.0% | -29.0% | -76.3% | |
| May 20, 2021 | HROW Harrow, Inc. | - | Sell | 10,000 | $10.75 | $107,500.00 | -10.0% | -12.9% | -40.6% | |
| Mar 13, 2019 | OCUL Ocular Therapeutix, Inc | Director | Buy | 56,441 | $4.33 | $244,389.53 | +129.6% | - | - | |
| Dec 19, 2016 | HROW Harrow, Inc. | Director | Buy | 100,000 | $1.79 | $179,000.00 | New | - | - |